Last reviewed · How we verify
NCT05295082
Accuracy of Trephination-based Versus Drilling-based Guided Dental Implant Placement
NA trial testing guided trephination-based drilling protocol in Single Tooth Lost in 22 participants. Completed in 30 April 2024.
20 June 2023
Quick facts
| Lead sponsor | Mohammed Ramadan |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 22 |
| Start date | 1 April 2022 |
| Primary completion | 20 June 2023 |
| Estimated completion | 30 April 2024 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- guided trephination-based drilling protocol
- guided Conventional drilling-based protocol
Conditions studied
- Single Tooth Lost — all drugs for Single Tooth Lost →
- Partially Edentulous Maxilla — all drugs for Partially Edentulous Maxilla →
Sponsor
Mohammed Ramadan
Who can join
Adults 20 to 50, any sex, with Single Tooth Lost or Partially Edentulous Maxilla. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study will be initiated to compare the accuracy of implant placement using the guided trephination drilling protocol and the guided conventional drilling protocol.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05295082
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05295082 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Mohammed Ramadan
- Last refreshed: 14 August 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05295082.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing